Literature DB >> 3106494

The production of tumor necrosis factor by mouse bone marrow-derived macrophages in response to bacterial lipopolysaccharide and a chemically synthesized monosaccharide precursor.

T J Sayers, I Macher, J Chung, E Kugler.   

Abstract

Lipid X, a monosaccharide biosynthetic precursor of lipid A, has been chemically synthesized and was shown to induce bone marrow-derived macrophages to release tumor necrosis factor (TNF) in vitro. However, relatively high amounts of lipid X were necessary for induction, and the levels of TNF were much less than those induced by small amounts of lipid A itself or LPS. Lipid X prepared by extraction of Escherichia coli mutants induced higher levels of TNF than the chemically synthesized material, but this is probably partially due to amounts of impurities in the extracted material. Pretreatment of macrophages with IFN-gamma resulted in the release of higher amounts of TNF on subsequent induction with either LPS or lipid X. In contrast, pretreatment of macrophages with LPS induced hyporesponsiveness for TNF production on subsequent rechallenge with LPS. Lipid X, on the other hand, was incapable of making macrophages hyporesponsive for TNF production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106494

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis.

Authors:  C Lam; E Schütze; J Hildebrandt; H Aschauer; E Liehl; I Macher; P Stütz
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.

Authors:  C Lam; J Hildebrandt; E Schütze; B Rosenwirth; R A Proctor; E Liehl; P Stütz
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Bacterial endotoxins: comparison of mitogenic, polyclonal, antibody-inducing and toxicity activities.

Authors:  J Sourek; M Svobodová; R Dvorák; J Müller; K Sůla; K Nouza
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

4.  Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

5.  c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages.

Authors:  A Descoteaux; G Matlashewski
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.

Authors:  P Y Perera; C L Manthey; P L Stütz; J Hildebrandt; S N Vogel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Mycoplasma capricolum membranes induce tumor necrosis factor alpha by a mechanism different from that of lipopolysaccharide.

Authors:  T Sher; S Rottem; R Gallily
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Receptor-mediated endocytosis of fucosylated neoglycoprotein by macrophages.

Authors:  K Sarkar; H S Sarkar; L Kole; P K Das
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

9.  Bacterial endotoxins as potential antitumor agents. Tumor mass loss in mice treated with bacterial lipopolysaccharides of Shigella dysenteriae serovar 1.

Authors:  J Sourek; C Oravec; D S Männel
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

Review 10.  Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.

Authors:  B Sherry; A Cerami
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.